RCEL
RCEL
NASDAQ · Biotechnology

Avita Medical Inc

$16.59
+0.91 (+5.80%)
As of Nov 14, 2:24 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 1 10%
Sell 1 10%
Price Target
Analyst Price Target +108.6% upside
Low Target $23.82
Average Target $34.61
High Target $34.97
Current Price $16.59
Current
$16.59
Target
$34.61
$23.82 $34.61 avg $34.97
Scenario Analysis
Bear Case
$23.82
43.6%
Low target
Base Case
$34.61
+108.6%
Avg target
Bull Case
$34.97
+110.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$18.43
-10.0% from high
52-Week Low
$3.22
+415.2% from low
Target vs 52W High
$34.61
+87.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%